PF

Paul R. Fatheree

TI Theravance Biopharma R&D Ip: 2 patents #10 of 35Top 30%
📍 San Francisco, CA: #1,119 of 5,107 inventorsTop 25%
🗺 California: #13,043 of 60,394 inventorsTop 25%
Overall (2017): #117,510 of 506,227Top 25%
2
Patents 2017

Issued Patents 2017

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
9725470 Substituted naphthyridines as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Dante D. Podesto, Gary E. L. Brandt, Melissa Fleury +1 more 2017-08-08
9630960 Quinolinone-carboxamide compounds as 5-HT4 receptor agonists Daniel Marquess, S. Derek Turner, Daniel D. Long, Seok-Ki Choi, Adam A. Goldblum 2017-04-25